DESIGN OF AN OPEN-LABEL, MULTICENTRE, NON-INTERVENTIONAL STUDY OF ZONISAMIDE AS FIRST-LINE ADJUNCTIVE TREATMENT IN ADULTS WITH PARTIAL EPILEPSY: THE ZOOM STUDY

被引：0
|
作者：
Baulac, M. [1 ]
Rugg-Gunn, F. [2 ]
Chouette, I. [3 ]
机构：
[1] Neurol Hop Pitie Salpetriere, Paris, France
[2] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[3] Eisai Europe Ltd, Hatfield, Herts, England
来源：
EPILEPSIA | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [21] Quality of life in patients with partial-onset seizures under adjunctive therapy with zonisamide: results from a prospective non-interventional surveillance study
    Helmstaedter, Christoph
    Stefan, Hermann
    Witt, Juri-Alexander
    [J]. EPILEPTIC DISORDERS, 2011, 13 (03) : 263 - 276
  • [22] Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study
    Jianqiu Wu
    Yongping Song
    Liping Su
    Li Xu
    Tingchao Chen
    Zhiyun Zhao
    Mingzhi Zhang
    Wei Li
    Yu Hu
    Xiaohong Zhang
    Yuhuan Gao
    Zuoxing Niu
    Ru Feng
    Wei Wang
    Jiewen Peng
    Xiaolin Li
    Xuenong Ouyang
    Changping Wu
    Weijing Zhang
    Yun Zeng
    Zhen Xiao
    Yingmin Liang
    Yongzhi Zhuang
    Jishi Wang
    Zimin Sun
    Hai Bai
    Tongjian Cui
    Jifeng Feng
    [J]. BMC Cancer, 16
  • [23] Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
    Stein, Alexander
    Quidde, Julia
    Schroeder, Jan Klaus
    Goehler, Thomas
    Tschechne, Barbara
    Valdix, Annette-Rosel
    Hoeffkes, Heinz-Gert
    Schirrmacher-Memmel, Silke
    Wohlfarth, Tim
    Hinke, Axel
    Engelen, Andreas
    Arnold, Dirk
    [J]. BMC CANCER, 2016, 16
  • [24] Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study
    Wu, Jianqiu
    Song, Yongping
    Su, Liping
    Xu, Li
    Chen, Tingchao
    Zhao, Zhiyun
    Zhang, Mingzhi
    Li, Wei
    Hu, Yu
    Zhang, Xiaohong
    Gao, Yuhuan
    Niu, Zuoxing
    Feng, Ru
    Wang, Wei
    Peng, Jiewen
    Li, Xiaolin
    Ouyang, Xuenong
    Wu, Changping
    Zhang, Weijing
    Zeng, Yun
    Xiao, Zhen
    Liang, Yingmin
    Zhuang, Yongzhi
    Wang, Jishi
    Sun, Zimin
    Bai, Hai
    Cui, Tongjian
    Feng, Jifeng
    [J]. BMC CANCER, 2016, 16
  • [25] Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
    Alexander Stein
    Julia Quidde
    Jan Klaus Schröder
    Thomas Göhler
    Barbara Tschechne
    Annette-Rosel Valdix
    Heinz-Gert Höffkes
    Silke Schirrmacher-Memmel
    Tim Wohlfarth
    Axel Hinke
    Andreas Engelen
    Dirk Arnold
    [J]. BMC Cancer, 16
  • [26] A multicentre, open-label phase II study of irinotecan, capecitabine, and oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Lui, Arthur Gregory Ang
    Mulder, Karen E.
    Brezden-Masley, Christine
    Vickers, Michael M.
    Monzon, Jose Gerard
    Kennecke, Hagen F.
    Goel, Rakesh
    Ghosh, Sunita
    Marginean, Horia
    Vos, Larissa Joy
    Raynard, SeeSee Juliana
    Young, Kristine Lee
    Fields, Anthony L. A.
    Maroun, Jean Alfred
    Spratlin, Jennifer L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] A Phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer.
    Cartwright, TH
    Lopez, T
    Vukelja, SJ
    Encarnacion, C
    Boehm, KA
    Asmar, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 284S - 284S
  • [28] Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study
    Hosoya, Kei
    Komachi, Taro
    Masaki, Katsunori
    Suzaki, Isao
    Saeki, Hidehisa
    Kanda, Naoko
    Nozaki, Makoto
    Kamide, Yosuke
    Matsuwaki, Yoshinori
    Kobayashi, Yoshiki
    Ogino, Eriko
    Osada, Shin-Ichi
    Usukura, Norihiro
    Kurumagawa, Toshikazu
    Ninomia, Junya
    Asako, Mikiya
    Nakamoto, Keitaro
    Yokoi, Hidenori
    Ohyama, Manabu
    Tanese, Keiji
    Kanzaki, Sho
    Fukunaga, Koichi
    Ebisawa, Motohiro
    Okubo, Kimihiro
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 861 - 872
  • [29] Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial
    Guerrini, Renzo
    Rosati, Anna
    Bradshaw, Kate
    Giorgi, Luigi
    [J]. EPILEPSIA, 2014, 55 (04) : 568 - 578
  • [30] Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study
    Fernandez, Oscar
    Izquierdo, Guillermo
    Aguera, Eduardo
    Ramo, Cristina
    Hernandez, Miguel
    Silva, Diego
    Walker, Rob
    Butzkueven, Helmut
    Wang, Chenyu
    Barnett, Michael
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (03)
12345